A cosmetic or dermatological composition contains by weight (a) a red light-filtering colorant (0.01-5%); and (b) an antiinflammatory agent (0.0001-10%). ACTIVITY : Dermatological; Antiinflammatory MECHANISM OF ACTION : None given in the specification.

A composition comprising a basic drug, a drug which forms a zwitterion, or a salt of either entity, admixed with a polymer selected from hydroxypropylmethylcellulose acetate succinate (HPMCAS), cellulose acetate trimellitate (CAT), cellulose acetate phthalate (CAP), hydroxypropylcellulose acetate phthalate (HPCAP), hydroxypropylmethyl-cellulose acetate phthalate (HPMCAP), and methylcellulose acetate phthalate (MCAP). The compositions having improved solubility, hence bioavailability, in the small intestine; Processes for testing such compositions, and methods of using such compositions. The compositions comprise the basic drug, zwitterion, or salt and one or more of the aforementioned polymers. The invention further relates to a method for increasing the bioavailability of a basic or a zwitterionic drug comprising co-administering the basic drug, the zwitterionic drug, or the salt, with one or more of the aforementioned polymers.

Chemical patent from PubChem database. Patent Number: AT-E400594-T1. Title: Pharmaceutical Formulation and Method of Use. Filing Date: 2001-01-07. Inventors: Patel, Amit, Jones, Michael. Abstract: The invention relates to pharmaceutical formulations containing active ingredients and methods for their therapeutic use in treating various medical c... IPC Classifications: B01J, C07C, C07D. This patent covers 39 claims related to 4 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.

A polymerizable composition is formed from (a) a polymerizable olefinically unsaturated substance, (b) a phosphorus oxyacid and an organic amine, at least one of which bears a polymerizable olefinically unsaturated group and optionally (c) a particulate inorganic material. Such compositions are useful in dental applications.

N-(Azolylcarbamyl)-hydroxylamines of the formula (I) where R is unsubstituted or substituted alkyl, alkenyl, alkoxyalkyl or cycloalkyl, or unsubstituted or substituted phenyl, phenylalkyl, phenylalkenyl or phenoxyalkyl, R1 is alkyl, alkenyl, alkoxyalkyl, alkylthioalkyl, cycloalkyl, cycloalkylalkyl or unsubstituted or substituted benzyl, Y is CH or N and R2 and R3 are each hydrogen or alkyl, and fungicides which contain these compounds.

A pharmaceutical composition comprising a pharmaceutically effective amount of a pharmaceutically active substance and a pharmaceutically acceptable carrier including a cationic excipient, wherein said cationic excipient is a labile ester of betaine and a lipophilic alcohol having at least one primary hydroxyl group. Also, the use of a labile ester of betaine and a lipophilic alcohol having at least a primary hydroxyl group as a cationic excipient in a carrier for a pharmaceutical composition comprising a pharmaceutically active substance.

Chemical patent from PubChem database. Patent Number: AT-E400444-T1. Title: Method of Treatment Using Chemical Compounds. Filing Date: 2006-11-26. Inventors: Rodriguez, Juan, White, Jennifer. Abstract: Methods for treating diseases using specific chemical compounds are provided, including dosing regimens and combination therapies for enhanced therape... IPC Classifications: C07C, C07B, A61K. This patent covers 34 claims related to 8 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.

Disclosed are active substance combinations containing an oxime ether derivative of formula (I) (trifloxystrobin), phosphonic acid or a phosphonate such as fosetyl-Al, and folpet, as well as the use thereof as fungicides.

Chemical patent from PubChem database. Patent Number: AT-E399842-T1. Title: Polymorphic Forms of Active Compounds. Filing Date: 1995-11-24. Inventors: Kim, Young-Soo, Taylor, Elizabeth. Abstract: The invention describes polymorphic forms of active pharmaceutical compounds, each characterized by distinct crystallographic and thermal properties. IPC Classifications: B01J, C07C, C07D. This patent covers 20 claims related to 4 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.

Chemical patent from PubChem database. Patent Number: AT-E399536-T1. Title: Novel Pharmaceutical Composition. Filing Date: 2005-01-20. Inventors: Wilson, James, Brown, Patricia, Lee, David. Abstract: The present invention relates to a novel pharmaceutical composition comprising one or more active pharmaceutical ingredients and pharmaceutically acce... IPC Classifications: C07C, C07B, A61K. This patent covers 15 claims related to 5 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.